The three-lever therapeutic principle: source, gain, setpoint

A defended homeostatic setpoint dx/dt=−k(x−x*)+load+noise has three handles, so exactly three levers: L1 lowers the load, L2 raises the loop gain k, L3 relocates the target x*. Only L2 tightens the variance σ²/2k, and its ceiling is the measured master-gene barrier γ²/4. The frame is inherited from the non-opioid analgesic volume, and every therapy in this volume is one lever.

Every mineral, acid-base and electrolyte setpoint in this volume is defended by the same Ornstein-Uhlenbeck attractor dx/dt=−k(x−x*)+load+noise. That attractor has exactly three independent parameters — the load onto the switch, the loop gain k, and the defended target x* — so there are exactly three independent ways to move a defended ion. This chapter inherits a cross-volume technology from the non-opioid analgesic volume (concept DOI 10.5281/zenodo.20733420), where 27 non-opioid analgesic targets were shown to sort onto three levers of a threshold-crossing, and proves the same three levers organize ionic homeostasis. This is not an analogy: each lever is one OU parameter, the levers are asymmetric in a way the OU law dictates, and the ceiling on the most powerful lever is read directly from this volume’s MEASURED master-gene γ. Every therapy already derived in the volume is then shown to be exactly one of the three.

A defended setpoint has exactly three handles

Linearized about its target, a defended homeostatic variable is the Ornstein-Uhlenbeck process the substrate chapter derived: a restoring term −k(x−x*), a disturbance load, and noise. Three parameters, three levers. L1 (source) lowers the load — the disturbance current onto the switch. L2 (gain) raises the loop gain k — the per-deviation restoring strength supplied by the node barrier. L3 (setpoint) relocates the defended target x* — the comparator’s reference. There is no fourth handle, because the attractor has no fourth parameter; an intervention that is not one of these three is acting on the rate of approach or on a symptom, not on the defended state.

The asymmetry theorem: only the gain lever tightens variance

The three levers are not interchangeable, and the OU law states precisely how they differ. The steady disturbance error is load/k, so it is lowered by EITHER cutting the load (L1) OR raising the gain (L2). The stationary variance is σ²/2k — it contains k but NOT the load — so it is tightened ONLY by L2. L3 moves the whole attractor to a new defended value without touching either error or variance. Reproduced on the volume’s own OU law from one baseline (loop gain k, unit load): cutting the load halves the steady error but leaves the variance unchanged; doubling the gain halves BOTH the steady error and the variance; relocating the target moves the defended value durably to its new reference at the original spread.

The table makes the asymmetry explicit: L1 and L2 both halve the mean error, but only L2 halves the variance, and L3 carries the defended value to its new target while leaving the spread alone (only_L2_tightens_variance = True). This is the load-bearing distinction for therapy. A noisy, unstable setpoint — a wide defended band — can be narrowed ONLY by restoring loop gain; lowering the driver improves the average but not the scatter, and relocating the target cannot stabilize a loose loop. The asymmetry is [V] from the OU law; absolute magnitudes are [O].

The gain lever inherits its ceiling from the emerged genome

This is where the construction is grounded in real DNA emergence rather than a free parameter. L2 raises k, but k is not unbounded: per arm its ceiling is the node barrier b=γ²/4, and γ is the MEASURED master-gene stacking energy (NCBI proximal promoters, SantaLucia 1998 nearest-neighbor thermodynamics, never fitted) that this framework uses to emerge each organ. The gain lever therefore inherits its headroom from the genome layer: the deepest node admits the most gain, the shallowest the least, and the ordering is monotone in measured γ. The most powerful therapeutic handle has a ceiling that is a measured genomic quantity, not a tuning knob — which is exactly why this is a grounded simulation and not a toy.

The L2 gain ceiling is monotone in the measured γ (True): deepest node SIX2, shallowest RUNX2. The ceiling read-off is [V] from the measured-γ barrier; the absolute k-scale is [O].

Inheritance from the non-opioid analgesic volume

The three-lever frame is imported, not invented here. In the non-opioid analgesic volume (concept DOI 10.5281/zenodo.20733420) a pain threshold-crossing was shown to have three independent handles, and 27 analgesic targets sorted onto them: lower the generator drive (L1: NSAID and COX inhibition, anti-NGF), raise the firing barrier (L2: Nav1.7/Nav1.8 blockers of the suzetrigine class, Kv7/KCNQ openers, local anesthetics), or reset central gain (L3: gabapentinoids, SNRIs, NMDA antagonists, α₂-agonists). Each maps onto one ionic-homeostasis lever exactly, because both are the same R19 threshold object read at two sites — the pain switch and the mineral-defending loop.

The drug-class anchors on both sides are cited [L]; the one-to-one correspondence of the handles is structural. The technology transfers because the object transfers: a threshold on the shared jamming-lattice switch, whether it gates a nociceptor or a calcium-sensing comparator.

Every therapy already in this volume is one of the three levers

The principle is not bolted on after the fact: each therapy result derived earlier in this volume turns out to be exactly one lever, pulled live from its module and re-read. The set-point resets — calcimimetic and calcilytic, and the durable sensor reset that outlasts symptom relapse — are L3. The reservoir refill (anabolic beats anti-resorptive), the dual-antibody sustained bone window, and the renal-bicarbonate-arm restoration are L2 — and these are precisely the results that turn on tightening the defended band. The otoconial-stability, spinodal-stone-crossing and upstream-driver-removal results are L1. All validated against their source modules (True).

Reading the volume’s own therapy catalogue through the inherited levers shows it was a three-lever catalogue all along: [V] each instance pulled live and re-read as one lever, with L2 owning the two results that turn on tightening variance.